PubMed Health⌕ Search

PubMed · 7869992

Dosimetry for asymmetric x-ray fields.

Abstract

Conventional linear accelerators have four field-defining jaws or collimators. Usually, one set of the two opposing jaws moves concurrently to define the field width and the other set defines the field length. The resultant square or rectangular field will have the field centerline coincide with the collimator axis. However, some modern linacs have independent collimators or jaws that can be set asymmetrically. In this case, one of the two opposing jaws can be closed down independently of the other one to define an asymmetric field of smaller dimension. The field center now does not coincide with the collimator axis. Asymmetric collimators have found many clinical applications, but have complicated the dosimetry for physicists. Data acquisition and treatment planning implementations are tedious and complicated. An algorithm has been developed to correct for the reduced dose in the smaller asymmetric field. The approach used is similar in principle to the Day's equivalent field calculation. The difference in dose between an asymmetric and a symmetric radiation field is accounted for by a correction factor that is a function of the asymmetric and symmetric field sizes, off axis distance, and depth of measurement. The correction method presented here applies only to the closing down of one independent jaw. Beam profiles for asymmetric fields are measured for both the 6 and 10 MV photon beams.(ABSTRACT TRUNCATED AT 250 WORDS)

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

W Kwa, R O Kornelsen, R W Harrison, E el-Khatib. 1994. Dosimetry for asymmetric x-ray fields.. https://doi.org/10.1118/1.597260

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗